Oestrogen and attacks of migraine with and without aura (Q35781144)

10 August 2017

1 reference

title

Oestrogen and attacks of migraine with and without aura (English)

1 reference

10 August 2017

1 reference

1 reference

E Anne MacGregor

1

1 reference

10 August 2017

publication date

1 June 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

354-361

1 reference

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Epidemiology of headache in a general population--a prevalence study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Menstrual Migraine in A Representative Dutch Population Sample: Prevalence, Disability and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Epidemiology of headache and migraine in women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Progesterone suppositories and pessaries in the treatment of menstrual migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Migraine and menstruation: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Relationship of headache to phase of the menstrual cycle among young women: a daily diary study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Menstrual cycle and headache in a population sample of migraineurs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Prevalence of migraine on each day of the natural menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Progesterone in the treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

The role of progesterone in menstrual migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

The role of estradiol withdrawal in the etiology of menstrual migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Double-blind controlled trial of a micronized preparation of flumedroxone (Demigran) in prophylaxis of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

The effect of oral contraceptives on migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

The relationship of headache frequency to hormone use in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Headache and Sex Hormone Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Headaches in the first post partum week and their relationship to migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Migraine and reporoductive hormones throughout the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Prevention of menstrual migraine by percutaneous oestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Menstrual migraine: a double-blind trial of percutaneous estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

1 reference

7 January 2021

Treatment of menstrual migraine by oestradiol implants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Treatment of a Patient with Severe Menstrual Migraine Using the Depot LHRH Analogue Zoladex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Ovarian steroid levels in migraine with and without aura

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Focal migraine and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Migraine occurring for the first time in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Estrogen replacement and migraine aura

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Pharmacokinetics of oestrogens and progestogens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Case-control study of migraine and risk of ischaemic stroke in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Recommendations on the Risk of Ischaemic Stroke Associated With Use of Combined Oral Contraceptives and Hormone Replacement Therapy in Women With Migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

Estrogen replacement therapy: indications and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900768-9

7 January 2021

10.1016/S1474-4422(04)00768-9

Identifiers

DOI

1 reference

10 August 2017

1 reference